Predictive Value of Carotid Distensibility Coefficient for Cardiovascular Diseases and All-Cause Mortality: A

Chuang Yuan1, Jing Wang2,3, Michael Ying2

  • 1Medical Research Center, Changsha Central Hospital, Changsha, Hunan, China.

Plos One
|April 6, 2016
PubMed

Insights

Carotid distensibility coefficient (DC) significantly predicts cardiovascular diseases and mortality. Lower carotid DC indicates higher risk, aiding early identification and treatment of high-risk patients.

Area of Science:

  • Vascular Biology and Medicine
  • Cardiovascular Disease Risk Assessment
  • Biomarkers for Atherosclerosis

Background:

  • Arterial stiffness is a known risk factor for cardiovascular (CV) events and mortality.
  • Carotid distensibility coefficient (DC) reflects local arterial stiffness and is accessible via imaging.
  • The predictive value of carotid DC for CV diseases and mortality requires further clarification.

Purpose of the Study:

  • To determine the pooled predictive value of carotid distensibility coefficient (DC) for cardiovascular diseases and all-cause mortality.
  • To assess the association between carotid DC and future adverse CV outcomes.
  • To evaluate carotid DC as a potential biomarker for cardiovascular risk stratification.

Main Methods:

  • A meta-analysis was conducted.
  • Included 11 longitudinal studies with a total of 20,361 participants.
  • Analyzed the predictive value of carotid DC for CV events, CV mortality, and all-cause mortality.

Main Results:

  • Carotid DC was a significant predictor of total CV events, CV mortality, and all-cause mortality.
  • Lowest quartile of DC was associated with increased risk ratios for CV events (1.19), CV mortality (1.09), and all-cause mortality (1.65).
  • A 1 SD decrease in DC increased risk by 13% for CV events, 6% for CV mortality, and 41% for all-cause mortality.

Conclusions:

  • Carotid DC is a significant predictor of future cardiovascular diseases and all-cause mortality.
  • Carotid DC can aid in identifying high-risk individuals for early diagnosis and treatment.
  • This finding supports the use of carotid DC in cardiovascular risk assessment.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
767
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
728
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
837